ScienceDaily
New Alzheimer's drug repairs DNA damage and reduces brain inflammation
A repurposed spinal cord injury drug has shown striking results in mouse models of Alzheimer's, repairing DNA damage and reducing brain inflammation while targeting multiple disease pathways simultaneously. Unlike most Alzheimer's treatments that focus narrowly on amyloid or tau proteins, KCL-286's broader mechanism could address more of the disease's complexity. Its existing human safety data puts it ahead of most experimental candidates, potentially accelerating the path to clinical trials.
Read article →Phys.org
In search of life beyond our solar system: Atmosphere detected on a habitable-zone rocky world
Astronomers have detected an atmosphere around a rocky, Earth-sized planet situated in the habitable zone of a distant star — a first in the history of exoplanet research. The discovery marks the strongest evidence yet that worlds capable of supporting life may exist beyond our solar system. For scientists searching for signs of life elsewhere in the universe, it represents a fundamental shift from theory to tangible possibility.
Read article →ScienceDaily
New “living plastic” self-destructs in just 6 days without leaving microplastics
Researchers have engineered a new biodegradable plastic embedded with living bacteria that completely destroys itself within six days when triggered. Unlike conventional plastics, the material leaves behind no microplastic residue. The breakthrough could offer a viable alternative for single-use applications, one of the most persistent drivers of global plastic pollution.
Read article →ScienceDaily
This sugar-coated therapy boosted survival against deadly brain cancer by 50% in mice
Researchers have developed sugar-coated nanoparticles capable of crossing the blood-brain barrier to deliver tumor-suppressing genetic instructions directly into glioblastoma cells. In mouse studies, the approach increased median survival by 50% and shrank tumors without detectable harm to surrounding organs. The breakthrough is particularly significant because bypassing the blood-brain barrier has long been one of the central obstacles in treating this aggressive and almost universally fatal cancer.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →